These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6945426)

  • 1. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
    Tsujimoto M
    J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of IgE antibody formation by tubercle bacilli and muramyl peptide].
    Kishimoto T
    Kekkaku; 1980 Oct; 55(10):467-70. PubMed ID: 6785511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Potentiation of immune responses to influenza split virus vaccine by synthetic 6-O-acyl-muramylpeptides].
    Okunaga T
    Osaka Daigaku Shigaku Zasshi; 1980 Jun; 25(1):29-52. PubMed ID: 6935421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological properties of synthetic glycopeptides stimulating immunogenesis and nonspecific resistance].
    Dzheksenbaev OSh
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):13-8. PubMed ID: 7032159
    [No Abstract]   [Full Text] [Related]  

  • 5. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
    Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of immune responses by muroctasin.
    Akasaki M
    Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
    Chedid L; Carelli C; Audibert F
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
    Audibert F; Chedid L
    Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant activity of some nonpyrogenic hydrophobic analogues of muramyl dipeptide in enhancing the primary humoral and cell mediated immune responses in guinea pig model.
    Saxena RP; Puri A; Saxena KC; Shukla R; Haq W; Rizvi SY; Kundu B; Mathur KB
    Indian J Exp Biol; 1991 Feb; 29(2):111-5. PubMed ID: 1869292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant and antitumor activities of quinonyl-N-acetylmuramyldipeptides.
    Azuma I; Yamawaki M; Uemiya M; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Imada I; Yamamura Y
    Gan; 1979 Dec; 70(6):847-8. PubMed ID: 535688
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds.
    Tsujimoto M; Kotani S; Shiba T; Kusumoto S
    Infect Immun; 1986 Sep; 53(3):517-21. PubMed ID: 3744549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
    Carelli C; Audibert F; Chedid L
    Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.
    Tsujimoto M; Kotani S; Kinoshita F; Kanoh S; Shiba T; Kusumoto S
    Infect Immun; 1986 Sep; 53(3):511-6. PubMed ID: 3744548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increase of non-specific resistance to infection by synthetic adjuvants].
    Parant M; Chedid L
    C R Seances Soc Biol Fil; 1979; 173(2):201-12. PubMed ID: 159749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses.
    Pearse MJ; Drane D
    Vaccine; 2004 Jun; 22(19):2391-5. PubMed ID: 15193400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of monoaminergic neurotransmitter systems in MDP-induced adjuvant effect.
    Strnadová V; Masek K
    Methods Find Exp Clin Pharmacol; 1991; 13(6):391-5. PubMed ID: 1679149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant activity and adjuvant arthritis].
    Tanaka A
    Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.
    Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S
    Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs.
    Uemiya M; Saiki I; Kusama T; Azuma I; Yamamura Y
    Microbiol Immunol; 1979; 23(8):821-3. PubMed ID: 120487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.